Developing novel therapeutics for the treatment of rare diseases.
Soleno Therapeutics to Present at the H.C. Wainwright Virtual BioConnect 2021 Conference
Soleno Therapeutics Provides Regulatory Update on DCCR for the Treatment of Prader-Willi Syndrome